REGULATED PRESS RELEASE published on 12/09/2024 at 07:01, 1 year 3 months ago BIOFIRE® FILMARRAY® Tropical Fever Panel, un test PCR pour détecter l’origine des fièvres tropicales, obtient l’autorisation spéciale 510(k) de la FDA américaine Le test PCR BIOFIRE® FILMARRAY® Tropical Fever obtient l’autorisation spéciale 510(k) de la FDA pour détecter les fièvres tropicales. Un outil innovant pour un diagnostic précis et rapide BioMérieux Diagnostic Autorisation 510(k) Test PCR Fièvres Tropicales
BRIEF published on 12/05/2024 at 14:02, 1 year 3 months ago BioMérieux : Détails du Capital Social et des Droits de Vote en Novembre 2024 Droits De Vote Capital Social BioMérieux Actions Régulation Financière
BRIEF published on 12/05/2024 at 14:02, 1 year 3 months ago BioMérieux: Details of Share Capital and Voting Rights in November 2024 Share Capital Voting Rights BioMérieux Actions Financial Regulation
REGULATED PRESS RELEASE published on 12/05/2024 at 13:57, 1 year 3 months ago Novembre 2024 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant Informations mensuelles sur les droits de vote et actions de bioMérieux. Nombre total de droits de vote: 191 136 960 Autorité Des Marchés Financiers Droits De Vote BioMérieux Actions Informations Mensuelles
BRIEF published on 11/06/2024 at 09:59, 1 year 4 months ago État des Actions et Droits de Vote de bioMérieux pour Octobre 2024 Droits De Vote BioMérieux Actions Règlement Financier Octobre 2024
BRIEF published on 11/06/2024 at 09:59, 1 year 4 months ago Status of bioMérieux Shares and Voting Rights for October 2024 Voting Rights BioMérieux Actions Financial Regulation October 2024
REGULATED PRESS RELEASE published on 11/06/2024 at 09:54, 1 year 4 months ago Octobre 2024 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant bioMérieux informe sur le nombre total de droits de vote et d'actions au 31/10/2024. Les détails sont conformes à la réglementation financière en vigueur Droits De Vote BioMérieux Actions Règlement Général Informations Mensuelles
BRIEF published on 10/30/2024 at 07:06, 1 year 4 months ago BioMérieux Reports Solid Third-Quarter Performance in 2024 Financial Performance Diagnostic Solutions Sales Growth BioMérieux 2024 GO•28 Strategy
BRIEF published on 10/30/2024 at 07:06, 1 year 4 months ago BioMérieux : Croissance organique soutenue au troisième trimestre 2024 BioMérieux Croissance Organique Panels BIOFIRE® SPOTFIRE® GO•28
REGULATED PRESS RELEASE published on 10/30/2024 at 07:01, 1 year 4 months ago bioMérieux – Third-Quarter 2024 Business Review bioMérieux reports strong +10.3% organic sales growth, reaching €2,871m in the first nine months of 2024, driven by growth drivers like GO•28 strategic plan and BIOFIRE® respiratory panels. Q3 2024 shows an +11% organic sales growth with confirmation of 2024 full-year revised guidance. CEO Pierre Boulud expresses confidence in achieving targets BioMérieux Organic Sales Growth 2024 Guidance GO•28 Strategic Plan BIOFIRE Respiratory Panels
Published on 03/23/2026 at 02:00, 2 hours 56 minutes ago FutureGen Industries Announces Open Market Investments
Published on 03/20/2026 at 13:30, 2 days 15 hours ago Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/23/2026 at 03:35, 1 hour 21 minutes ago Deye 2026 Frankfurt Distributor & Partner Summit Concludes Successfully
Published on 03/22/2026 at 12:23, 16 hours 33 minutes ago Borussia Dortmund and Sebastian Kehl are ending their collaboration with immediate effect
Published on 03/20/2026 at 22:45, 2 days 6 hours ago Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 2 days 7 hours ago Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 19:00, 2 days 9 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 9 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 10 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 10 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA